3 Biotech. 2013 Apr;3(2):85-96. doi: 10.1007/s13205-012-0072-6. Epub 2012 Jun 10.

Trace elements and carcinogenicity: a subject in review.

3 Biotech

Stephen Juma Mulware

PMID: 28324563 PMCID: PMC3597132 DOI: 10.1007/s13205-012-0072-6

Abstract

Cancer is known to be a multi-step process, which involves different stages including initiation, promotion, progression and metastasis. Chemical carcinogens including most trace elements can change any of these processes to induce their carcinogenic effects. Various studies confirm that cancer arises from the accumulation of irreversible DNA damage, which results from multiple mutations in critical genes in the body organ. Chemical carcinogens most often directly or after xenobiotic metabolism, act as genotoxic causes to induce DNA damage. Genotoxic carcinogen refers to a group of chemicals capable of producing cancer by directly altering the genetic material of target cells. Other carcinogens are however classified as non-genotoxic, which represents chemicals that are capable of producing cancer by some secondary mechanism not related to direct gene damage. They act as tumor promoters, endocrine-modifiers, receptor mediators, immunosuppressant, or inducers of tissue-specific toxicity and inflammatory responses. The diversity of modes of action, of non-genotoxic carcinogens, the tissue and species specificity and the absence of genotoxicity makes it extremely hard to predict their carcinogenic potential. The roles of trace metals (some of which are either genotoxic or non-genotoxic) in cancer development and inhibition have a complex character and have raised many questions because of their essential and toxic effects on people's health. Trace metals such as cadmium, nickel, arsenic, beryllium and chromium (VI) have been recognized as human or animal carcinogens by International Agency for Research on Cancer (IARC). The Carcinogenic capability of these metals depends mainly on factors such as oxidation states and chemical structures. The oxidative concept in metal carcinogenesis proposes that complexes formed by these metals, in vivo, in the vicinity of DNA, catalyze redox reactions, which in turn oxidize DNA. The most significant effect of reactive oxygen species in the carcinogenesis progression is DNA damage, which results in DNA lesions like strand breaks and the sister-chromatid exchange. This article reviews the carcinogenicity of various trace elements.

Keywords: Carcinogenicity; Epidemiology; Exposure; ROS; Trace elements

References

1. Comb Chem High Throughput Screen. 2012 Mar;15(3):221-31 - PubMed
2. Cancer Lett. 2003 Nov 10;201(1):57-65 - PubMed
3. J Immunol. 2008 Feb 15;180(4):2704-12 - PubMed
4. Epidemiology. 2006 Jul;17(4):459-67 - PubMed
5. Mutat Res. 2012 Apr 11;744(1):8-11 - PubMed
6. Cancer Res. 1991 Nov 1;51(21):5837-42 - PubMed
7. Risk Anal. 1988 Dec;8(4):531-44 - PubMed
8. Toxicol Lett. 2003 Jul 20;143(2):123-31 - PubMed
9. Cancer Res. 1993 Apr 15;53(8):1739-42 - PubMed
10. Toxicol Sci. 2007 Feb;95(2):376-82 - PubMed
11. Chem Biol Interact. 1991;79(3):323-34 - PubMed
12. Basic Clin Pharmacol Toxicol. 2012 Jan;110(1):87-94 - PubMed
13. Sci Total Environ. 2008 Jan 15;389(1):1-9 - PubMed
14. J Nutr Biochem. 2004 Oct;15(10):572-8 - PubMed
15. Chem Res Toxicol. 1997 Apr;10(4):393-400 - PubMed
16. Am J Pathol. 1990 Nov;137(5):1121-42 - PubMed
17. J Biol Chem. 1997 Aug 1;272(31):19095-8 - PubMed
18. Nat Genet. 2008 Dec;40(12):1413-5 - PubMed
19. J Natl Cancer Inst. 1991 Oct 2;83(19):1380-5 - PubMed
20. J Clin Invest. 2002 Nov;110(10):1473-82 - PubMed
21. Cancer Res. 1975 Nov;35(11 Pt. 2):3481-7 - PubMed
22. World Health Organ Tech Rep Ser. 2006;(939):1-80, backcover - PubMed
23. J Environ Monit. 2004 Jun;6(6):74N-83N - PubMed
24. Mutat Res. 1991 May;248(1):177-85 - PubMed
25. Chem Biol Interact. 1991;79(2):217-28 - PubMed
26. IARC Monogr Eval Carcinog Risks Hum. 1989;47:291-305 - PubMed
27. Indian J Occup Environ Med. 2009 Aug;13(2):65-76 - PubMed
28. Altern Lab Anim. 2005 Jul;33 Suppl 1:177-82 - PubMed
29. Nutrition. 1995 Sep-Oct;11(5 Suppl):646-9 - PubMed
30. Nucleic Acids Res. 1994 Sep;22(17):3551-5 - PubMed
31. Arch Toxicol. 1980 Jul;45(2):81-92 - PubMed
32. Toxicol Appl Pharmacol. 2006 Jun 15;213(3):282-90 - PubMed
33. Environ Toxicol Pharmacol. 2008 Nov;26(3):263-71 - PubMed
34. IARC Monogr Eval Carcinog Risks Hum. 1991;52:363-472 - PubMed
35. PLoS One. 2012;7(2):e32426 - PubMed
36. Curr Med Chem. 2005;12(10):1161-208 - PubMed
37. J Immunol. 1999 Jul 15;163(2):1019-26 - PubMed
38. J Toxicol Environ Health. 1996 Jan;47(1):61-75 - PubMed
39. Ann Oncol. 2012 Nov;23(11):2866-2873 - PubMed
40. Toxicology. 2001 Aug 13;165(1):27-38 - PubMed
41. Environ Health Perspect. 1994 Sep;102 Suppl 3:119-25 - PubMed
42. Curr Med Chem. 2006;13(21):2513-25 - PubMed
43. Environ Health Prev Med. 2011 May;16(3):164-70 - PubMed
44. Am J Physiol Cell Physiol. 2000 Sep;279(3):C868-75 - PubMed
45. Genome Biol. 2009;10(10):R115 - PubMed
46. J Proteome Res. 2010 Dec 3;9(12):6380-91 - PubMed
47. Regul Toxicol Pharmacol. 1991 Oct;14(2):118-46 - PubMed
48. Science. 1974 Feb 1;183(4123):449 - PubMed
49. Nat Genet. 2007 Mar;39(3):347-51 - PubMed
50. Food Addit Contam. 2007 May;24(5):447-534 - PubMed
51. Scand J Work Environ Health. 1989 Feb;15(1):1-12 - PubMed
52. Int Immunopharmacol. 2004 Feb;4(2):179-84 - PubMed
53. Toxicology. 2003 Nov 5;192(2-3):95-117 - PubMed
54. Scand J Work Environ Health. 1993;19 Suppl 1:67-70 - PubMed
55. Ann N Y Acad Sci. 1999;895:56-79 - PubMed
56. Free Radic Biol Med. 2004 Jun 1;36(11):1434-43 - PubMed
57. Epigenomics. 2010 Feb;2(1):87-104 - PubMed
58. Ann N Y Acad Sci. 1992 Nov 21;663:85-96 - PubMed
59. Mutat Res. 2001 Nov 15;498(1-2):47-55 - PubMed
60. Carcinogenesis. 1986 Sep;7(9):1527-33 - PubMed
61. Biometals. 2001 Sep-Dec;14(3-4):271-313 - PubMed
62. Mutat Res. 1987 Jul;186(1):35-42 - PubMed
63. Am J Respir Crit Care Med. 2008 May 1;177(9):1002-11 - PubMed
64. Toxicology. 2008 Jan 14;243(1-2):193-206 - PubMed
65. Vet Pathol. 2009 May;46(3):416-22 - PubMed

Publication Types

• Journal Article